ID
45174
Beschrijving
Principal Investigator: Dan Roden, MD, Vanderbilt University Medical Center, Nashville, TN, USA MeSH: Long QT Syndrome,Torsades de Pointes https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000331 The goal of this study was to identify genetic risk factors for drug-induced prolongation of the QT interval (diLQT) and the ventricular arrhythmia torsades de pointes (TdP). We conducted a genome-wide association study (GWAS) focusing on subjects with a history of long QT and/or TdP after taking medication. Controls for this study were individuals with a history of cardiac arrhythmias who had begun treatment with potentially QT-prolonging antiarrhythmics. An additional control group of normal volunteers were given ibutilide, a drug with documented proarrhythmic properties. All study participants were recruited and treated/evaluated at Vanderbilt University Medical Center. This study was conducted by the Pharmacogenomics of Arrhythmia Therapy subgroup of the Pharmacogenetics Research Network, a nationwide collaboration of scientists studying the genetic contributions to drug response variability. Genotyping was performed by the RIKEN research institute in Japan using the Illumina 610 Quad Beadchip platform.
Link
Trefwoorden
Versies (2)
- 2022-08-22 2022-08-22 - Simon Heim
- 2022-10-12 2022-10-12 - Adrian Schulz
Houder van rechten
Dan Roden, MD, Vanderbilt University Medical Center, Nashville, TN, USA
Geüploaded op
12 oktober 2022
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
dbGaP phs000331 PGRN-RIKEN: Genome-Wide Association Study of Drug-Induced Long-QT Syndrome
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subjects with a history of long QT and/or TdP after taking medication and control individuals with a history of cardiac arrhythmias who had begun treatment with potentially QT-prolonging antiarrhythmics.
- Samples of subjects with a history of long QT and/or TdP after taking medication and control individuals with a history of cardiac arrhythmias who had begun treatment with potentially QT-prolonging antiarrhythmics.
- Affection status, sex, age, ethnicity, and drugs causing diLQT and/or TdP among subjects with a history of long QT and/or TdP after taking medication and control individuals with a history of cardiac arrhythmias who had begun treatment with potentially QT-prolonging antiarrhythmics.
Similar models
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subjects with a history of long QT and/or TdP after taking medication and control individuals with a history of cardiac arrhythmias who had begun treatment with potentially QT-prolonging antiarrhythmics.
- Samples of subjects with a history of long QT and/or TdP after taking medication and control individuals with a history of cardiac arrhythmias who had begun treatment with potentially QT-prolonging antiarrhythmics.
- Affection status, sex, age, ethnicity, and drugs causing diLQT and/or TdP among subjects with a history of long QT and/or TdP after taking medication and control individuals with a history of cardiac arrhythmias who had begun treatment with potentially QT-prolonging antiarrhythmics.
C1706256 (UMLS CUI [1,2])
C0001779 (UMLS CUI [1,3])
C0023976 (UMLS CUI [1,4])
C0040479 (UMLS CUI [1,5])
C1706256 (UMLS CUI [1,2])
C0577807 (UMLS CUI [1,3])
C0743284 (UMLS CUI [1,4])
C1706256 (UMLS CUI [1,2])
C0577807 (UMLS CUI [1,3])
C0743284 (UMLS CUI [1,4])
C1706256 (UMLS CUI [1,2])
C0743284 (UMLS CUI [1,3])
C1623258 (UMLS CUI [1,4])
C0040479 (UMLS CUI [1,5])
C1512693 (UMLS CUI [2,1])
C1706256 (UMLS CUI [2,2])
C1395815 (UMLS CUI [2,3])
C1623258 (UMLS CUI [2,4])
C1298908 (UMLS CUI [2,5])
C0040479 (UMLS CUI [2,6])
C1706256 (UMLS CUI [1,2])
C1706256 (UMLS CUI [1,2])
C0302353 (UMLS CUI [1,3])
C1706256 (UMLS CUI [1,2])
C0038525 (UMLS CUI [1,3])
C0574845 (UMLS CUI [1,4])
C1706256 (UMLS CUI [1,2])
C0010055 (UMLS CUI [1,3])
C0332152 (UMLS CUI [1,4])
C0574845 (UMLS CUI [1,5])
C1706256 (UMLS CUI [1,2])
C0184666 (UMLS CUI [1,3])
C0020672 (UMLS CUI [1,4])
C4759356 (UMLS CUI [1,5])
C1706256 (UMLS CUI [1,2])
C1141890 (UMLS CUI [1,3])
C0332152 (UMLS CUI [1,4])
C0332162 (UMLS CUI [1,5])
C0441471 (UMLS CUI [1,6])
C1706256 (UMLS CUI [1,2])
C0023530 (UMLS CUI [1,3])
C1706256 (UMLS CUI [1,2])
C4039784 (UMLS CUI [1,3])
C0009932 (UMLS CUI [1,2])
C0009932 (UMLS CUI [1,2])
C0001779 (UMLS CUI [1,3])
C0009932 (UMLS CUI [1,2])
C0151878 (UMLS CUI [1,3])
C0003195 (UMLS CUI [1,4])
C0009932 (UMLS CUI [1,2])
C1298908 (UMLS CUI [1,3])
C0005841 (UMLS CUI [1,4])
C0009932 (UMLS CUI [1,2])
C0009932 (UMLS CUI [1,2])
C0001779 (UMLS CUI [1,3])
C0009932 (UMLS CUI [1,2])
C1298908 (UMLS CUI [1,3])
C0455633 (UMLS CUI [1,4])
C0009932 (UMLS CUI [1,2])
C0337672 (UMLS CUI [1,3])
C0009932 (UMLS CUI [1,2])
C0522054 (UMLS CUI [1,3])